
Shin Lin Chen
Examiner (ID: 17983, Phone: (571)272-0726 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1633, 1632 |
| Total Applications | 1467 |
| Issued Applications | 727 |
| Pending Applications | 150 |
| Abandoned Applications | 592 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6089365
[patent_doc_number] => 20110217779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'Compositions and Methods for Non-Targeted Activation of Endogenous Genes'
[patent_app_type] => utility
[patent_app_number] => 13/037742
[patent_app_country] => US
[patent_app_date] => 2011-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 50350
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20110217779.pdf
[firstpage_image] =>[orig_patent_app_number] => 13037742
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/037742 | Compositions and Methods for Non-Targeted Activation of Endogenous Genes | Feb 28, 2011 | Abandoned |
Array
(
[id] => 7766103
[patent_doc_number] => 20120034191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION'
[patent_app_type] => utility
[patent_app_number] => 13/033053
[patent_app_country] => US
[patent_app_date] => 2011-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4541
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034191.pdf
[firstpage_image] =>[orig_patent_app_number] => 13033053
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/033053 | EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION | Feb 22, 2011 | Abandoned |
Array
(
[id] => 7669038
[patent_doc_number] => 20110318307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'XIAP THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/033283
[patent_app_country] => US
[patent_app_date] => 2011-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 16566
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13033283
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/033283 | XIAP THERAPY | Feb 22, 2011 | Abandoned |
Array
(
[id] => 7734597
[patent_doc_number] => 20120016491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'LAMINATE SHEET ARTICLES FOR TISSUE REGENERATION'
[patent_app_type] => utility
[patent_app_number] => 13/033102
[patent_app_country] => US
[patent_app_date] => 2011-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3756
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20120016491.pdf
[firstpage_image] =>[orig_patent_app_number] => 13033102
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/033102 | Laminate sheet articles for tissue regeneration | Feb 22, 2011 | Issued |
Array
(
[id] => 8720148
[patent_doc_number] => 20130071365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'INDUCED HEPATOCYTES'
[patent_app_type] => utility
[patent_app_number] => 13/579038
[patent_app_country] => US
[patent_app_date] => 2011-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7593
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579038
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/579038 | INDUCED HEPATOCYTES | Feb 15, 2011 | Abandoned |
Array
(
[id] => 9496552
[patent_doc_number] => 08735365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 13/005579
[patent_app_country] => US
[patent_app_date] => 2011-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 26
[patent_no_of_words] => 31394
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13005579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/005579 | Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy | Jan 12, 2011 | Issued |
Array
(
[id] => 10032915
[patent_doc_number] => 09074223
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Vectors and methods for transducing B cells'
[patent_app_type] => utility
[patent_app_number] => 13/520921
[patent_app_country] => US
[patent_app_date] => 2011-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15794
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520921
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/520921 | Vectors and methods for transducing B cells | Jan 6, 2011 | Issued |
Array
(
[id] => 6189775
[patent_doc_number] => 20110172144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'METHODS FOR INCREASING EXPRESSION OF SERCA2A IN CARDIAC MUSCLE'
[patent_app_type] => utility
[patent_app_number] => 12/984552
[patent_app_country] => US
[patent_app_date] => 2011-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11002
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172144.pdf
[firstpage_image] =>[orig_patent_app_number] => 12984552
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/984552 | METHODS FOR INCREASING EXPRESSION OF SERCA2A IN CARDIAC MUSCLE | Jan 3, 2011 | Abandoned |
Array
(
[id] => 7560837
[patent_doc_number] => 20110274669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/976078
[patent_app_country] => US
[patent_app_date] => 2010-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17521
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20110274669.pdf
[firstpage_image] =>[orig_patent_app_number] => 12976078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/976078 | THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY | Dec 21, 2010 | Abandoned |
Array
(
[id] => 6040914
[patent_doc_number] => 20110093963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Enhanced Expression of Human or Humanized Immunoglobulin in Non-Human Transgenic Animals'
[patent_app_type] => utility
[patent_app_number] => 12/972290
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10778
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20110093963.pdf
[firstpage_image] =>[orig_patent_app_number] => 12972290
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/972290 | Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals | Dec 16, 2010 | Issued |
Array
(
[id] => 8066057
[patent_doc_number] => 20110243995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and Correspondingly Mutated MDM2-Protein Specific Alpha/Beta T-Cell Receptors'
[patent_app_type] => utility
[patent_app_number] => 12/952259
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15454
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20110243995.pdf
[firstpage_image] =>[orig_patent_app_number] => 12952259
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/952259 | Method for rational mutagenesis of α/βT-cell receptors and correspondingly mutated MDM2-protein specific α/βT-cell receptors | Nov 22, 2010 | Issued |
Array
(
[id] => 6009082
[patent_doc_number] => 20110061114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'NOVEL PRO258 GENE DISRUPTIONS, AND METHODS RELATING THERETO'
[patent_app_type] => utility
[patent_app_number] => 12/945589
[patent_app_country] => US
[patent_app_date] => 2010-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 74
[patent_no_of_words] => 172133
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20110061114.pdf
[firstpage_image] =>[orig_patent_app_number] => 12945589
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/945589 | NOVEL PRO258 GENE DISRUPTIONS, AND METHODS RELATING THERETO | Nov 11, 2010 | Abandoned |
| 12/925886 | Lung cancer therapy using an engineered respiratory syncytial virus | Nov 1, 2010 | Abandoned |
Array
(
[id] => 8477130
[patent_doc_number] => 20120276537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'HOMOLOGOUS RECOMBINATION IN THE OOCYTE'
[patent_app_type] => utility
[patent_app_number] => 13/504587
[patent_app_country] => US
[patent_app_date] => 2010-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14639
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504587
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/504587 | HOMOLOGOUS RECOMBINATION IN THE OOCYTE | Oct 27, 2010 | Abandoned |
Array
(
[id] => 6189722
[patent_doc_number] => 20110172121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'ALLOGENEIC STEM CELL BANK'
[patent_app_type] => utility
[patent_app_number] => 12/908143
[patent_app_country] => US
[patent_app_date] => 2010-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6472
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172121.pdf
[firstpage_image] =>[orig_patent_app_number] => 12908143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/908143 | ALLOGENEIC STEM CELL BANK | Oct 19, 2010 | Abandoned |
Array
(
[id] => 8749325
[patent_doc_number] => 08415155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-09
[patent_title] => 'Cardiomyocyte production'
[patent_app_type] => utility
[patent_app_number] => 12/907714
[patent_app_country] => US
[patent_app_date] => 2010-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 75
[patent_no_of_words] => 28360
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12907714
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/907714 | Cardiomyocyte production | Oct 18, 2010 | Issued |
Array
(
[id] => 8441923
[patent_doc_number] => 20120258539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'USE OF NIBP POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/499932
[patent_app_country] => US
[patent_app_date] => 2010-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 9967
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/499932 | USE OF NIBP POLYPEPTIDES | Oct 11, 2010 | Abandoned |
Array
(
[id] => 8875589
[patent_doc_number] => 08470552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'Strategy to reduce lactic acid production and control PH in animal cell culture'
[patent_app_type] => utility
[patent_app_number] => 12/903046
[patent_app_country] => US
[patent_app_date] => 2010-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10235
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12903046
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/903046 | Strategy to reduce lactic acid production and control PH in animal cell culture | Oct 11, 2010 | Issued |
Array
(
[id] => 6165840
[patent_doc_number] => 20110195505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'BACTERIAL STRAINS FOR BUTANOL PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/899760
[patent_app_country] => US
[patent_app_date] => 2010-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22558
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195505.pdf
[firstpage_image] =>[orig_patent_app_number] => 12899760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/899760 | BACTERIAL STRAINS FOR BUTANOL PRODUCTION | Oct 6, 2010 | Abandoned |
Array
(
[id] => 8979294
[patent_doc_number] => 20130212724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'Composition for Regenerating Hair Follicles Comprising CD36-Expressing Dermal Sheath Cells'
[patent_app_type] => utility
[patent_app_number] => 13/876608
[patent_app_country] => US
[patent_app_date] => 2010-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6556
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876608
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/876608 | Composition for Regenerating Hair Follicles Comprising CD36-Expressing Dermal Sheath Cells | Sep 28, 2010 | Abandoned |